SCHEMBL5037447

SCHEMBL5037447

CCOC(=O)[C@@](C)(OCC)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.45
MMP8 P22894 1/20 0.43
RAB9A P51151 3/20 0.42
LMNA P02545 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.41
TARBP2 Q15633 1/20 0.41
ALDH1A1 P00352 2/20 0.40
RECQL P46063 1/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPSR1 Q6W5P4 2/20 0.40
POLB P06746 1/20 0.40
NPC1 O15118 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5037444 1.00 PIN1 (0.45) PIN1MMP8RAB9ALMNACYP1A2
SCHEMBL7861200 0.91 PIN1 (0.50) PIN1MMP8LMNACYP1A2ALDH1A1
SCHEMBL5041186 0.86 CYP2C9 (0.49) RAB9ALMNACYP2C9ALDH1A1MAPT
SCHEMBL5041181 0.86 CYP2C9 (0.49) RAB9ALMNACYP2C9ALDH1A1MAPT
SCHEMBL12032244 0.83 CNR2 (0.49) PIN1MMP8RAB9ALMNACYP1A2
SCHEMBL7646777 0.83 ESR1 (0.47) LMNACYP1A2ALDH1A1MAPTKDM4E
SCHEMBL7242921 0.83 ESR1 (0.47) LMNACYP1A2ALDH1A1MAPTKDM4E
SCHEMBL11600385 0.82 PPARA (0.49) PIN1MMP8RAB9ALMNACYP1A2
SCHEMBL6187181 0.82 APP (0.45) PIN1MMP8LMNACYP1A2CYP2C9
SCHEMBL7986974 0.81 PIN1 (0.51) PIN1MMP8RAB9ALMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PIN1 3824/4885MMP8 159/4885RAB9A 124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.